Clinical trials in Hilversum – page 6

68 clinical trials in Hilversum, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Hilversum at a glance

clinical trials

Research sites1

Quick filters

68 trials in Hilversum

Open in trial search

Non-small cell lung cancer stage I+1

Not recruiting

Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

Registered drug

Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Infertility+2

Not recruiting

Study on Progesterone for Improving Birth Rates in Couples with Unexplained Infertility Undergoing Mild Ovarian Stimulation and Intrauterine Insemination

Registered drug

Study on Progesterone for Improving Birth Rates in Couples with Unexplained Infertility Undergoing Mild Ovarian Stimulation and Intrauterine Insemination

Registered drug

The Netherlands

Participants:18–64 years
Substances:Progesterone, Micronised
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Acute coronary syndrome

Not recruiting

Study on Reducing Bleeding by Omitting Aspirin in Patients with Non-ST Elevation Acute Coronary Syndrome

Registered drugNo placebo

Study on Reducing Bleeding by Omitting Aspirin in Patients with Non-ST Elevation Acute Coronary Syndrome

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Neoplasm malignant

Not recruiting

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

InvestigationalNo placebo

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Darolutamide
Sponsor:Bayer Consumer Care AG

Contact Research Centre

Bronchiolitis+2

Not recruiting

Study on Oxygen Levels for Children and Adolescents with Respiratory Distress: Focusing on Bronchiolitis, Viral Wheeze, and Lower Respiratory Tract Infection

Registered drugNo placebo

Study on Oxygen Levels for Children and Adolescents with Respiratory Distress: Focusing on Bronchiolitis, Viral Wheeze, and Lower Respiratory Tract Infection

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Oxygen
Sponsor:Spaarne Gasthuis

Contact Research Centre

Hormone-refractory prostate cancer

Not recruiting

Study Comparing Docetaxel Alone and Docetaxel with Radium-223 for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

Study Comparing Docetaxel Alone and Docetaxel with Radium-223 for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Radium RA 223 dichloride
Sponsor:Memorial Sloan Kettering Cancer Center

Contact Research Centre

Gastrooesophageal cancer

Not recruiting

Study on Liposomal Irinotecan, Carboplatin, or Oxaliplatin for First-Line Treatment in Patients with Advanced Esophagogastric Cancer

Registered drugNo placebo

Study on Liposomal Irinotecan, Carboplatin, or Oxaliplatin for First-Line Treatment in Patients with Advanced Esophagogastric Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

Registered drug

Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Durvalumab
Sponsor:Clinipace Global Limited

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Hilversum

What the registry says about research in the country

01 Oncology Research

Clinical trials focusing on various cancer treatments, including prostate cancer, renal cell carcinoma, and lymphoma. Studies are evaluating innovative therapeutic combinations and targeted treatments.

Metastatic prostate cancer treatments
B-cell lymphoma therapies
Targeted cancer medications

Several trials are investigating novel drug combinations to improve patient outcomes and survival rates.

02 Cardiovascular Studies

Research focusing on cardiovascular disease prevention and treatment, including studies on stroke prevention and heart conditions. New therapeutic approaches are being tested for improved patient care.

Stroke prevention in atrial fibrillation
Cardiovascular risk reduction
Blood pressure management

Trials aim to evaluate new medications for better cardiovascular outcomes.

03 Nephrology Research

Studies examining treatments for chronic kidney disease and related conditions. Research focuses on novel therapeutic combinations and disease progression management.

CKD progression prevention
Hypertension management
Renal function preservation

Innovative approaches are being tested to improve outcomes for patients with kidney disease.

Back to the Netherlands All countries